Pentax launches dengue fever test kit in Japan:
This article was originally published in Clinica
Executive Summary
Pentax has launched a compact diagnostic kit for the detection of dengue virus IgM antibodies in Japan. Commercialisation of the product follows successful international field tests last year. The set comprises 12 tests per kit, with a recommended price of Y20,000 ($178) per kit. Combined sales of Y300m are expected in the period to March 2006. Pentax noted it is also considering developing similar diagnostic kits to detect HIV and Japanese encephalitis antibodies.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.